PepDiana
Back to Evidence
Primary experimental recordPositive observation

PMC9143221::ACT053012

DFTavP1

Evidence text

Paper-level observation

Table 2: DFTavP1 MIC 8–16 µM against S. epidermidis 1457.
unknownConfidence: medium

Assay observation

Activity
Antimicrobial
Subtype
Anti-Gram+
Measure
MIC
Comparator
=
Raw observation
8–16 µM
Normalized measurement
=8 µM
Value minimum
8 µM
Value maximum
16 µM
Target
Staphylococcus epidermidis
Assay method
Not reported by source
Sequence
RWLRGLLSGLLRRLLSGLLL
Standardization
ready simple

Source publication

Improved Database Filtering Technology Enables More Efficient Ab Initio Design of Potent Peptides against Ebola Viruses

Pharmaceuticals · 2022

DOI 10.3390/ph15050521 PMC9143221
Parent mention

Related peptide identities

PEPDIA-PLP-002612

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.